nevirapine has been researched along with Weight Gain in 2 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
Weight Gain: Increase in BODY WEIGHT over existing weight.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chetty, T | 1 |
Carter, RJ | 1 |
Bland, RM | 1 |
Newell, ML | 1 |
Djadou, KE | 1 |
Ocloo, A | 1 |
Dokounor, D | 1 |
Agbodjan-Djossou, O | 1 |
Akakpossa, A | 1 |
Atakouma, DY | 1 |
2 other studies available for nevirapine and Weight Gain
Article | Year |
---|---|
HIV status, breastfeeding modality at 5 months and postpartum maternal weight changes over 24 months in rural South Africa.
Topics: Adult; Anti-HIV Agents; Breast Feeding; Female; Follow-Up Studies; HIV Infections; Humans; Infant; I | 2014 |
[Treatment of children born of AIDS mothers in Tsevie hospital regional center, Togo].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Breast Feeding; Child Health Services; Femal | 2007 |